A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorNational University Hospital, Singapore
About this trial
The goal of this clinical trial is to evaluate whether an electronic patient-reported outcome measure (ePROM)-guided flexible scheduling system can improve outpatient clinic resource utilisation in patients attending dermatology outpatient clinics for routine follow-up. The main questions it aims to answer are:
* Does the intervention reduce the number of actualised outpatient visits over 12 months compared with standard fixed scheduling? * Does the intervention group achieve higher adherence to monthly ePROM monitoring, as measured by the proportion of completed ePROM submissions?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Dermatology outpatients otherwise due for a follow-up appointment within six months.
Ability to independently navigate and complete ePROMs.
Ability to provide informed consent (including parental consent for minors).
Disqualifiers
Patients who require fixed or scheduled in-person visits, including those needing skin cancer surveillance, bedside procedures (e.g., liquid nitrogen therapy), surgical interventions, or routine blood tests for immunosuppressive therapy.
Trial design
Design model
Parallel
Treatments tested in this trial
Flexible ePROM-guided Scheduling System
BehavioralMonthly ePROM responses will feed a Bayesian decision system to determine appointment need, which will then be used to make recommendations to patients for scheduling of appointments.
electronic patient reported outcome measures (ePROMs)
BehavioralMonthly electronic patient reported outcome measures (ePROMs) surveys will be sent to patients' mobile devices to capture self-reported disease severity data.
Treatment groups
250 Participants
are divided into 2 treatment groupsGroup A: Intervention ArmExperimental treatment 2 interventions
Group B: Control ArmActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Number of actualised outpatient visits
Difference in actualised outpatient visits (in-person + teleconsult) over 12 months (effectiveness outcome).
Time frame
baseline to week 522
Proportion of completed monthly ePROMs
Difference in proportion of completed monthly ePROMs (implementation outcome)
Time frame
baseline to week 52Secondary outcomes
1
No-show rate
Number of appointments missed without prior rescheduling or cancellation
Time frame
baseline to week 522
Cancelled or rescheduled appointments
Appointments booked but cancelled or rescheduled before the actual appointment date
Time frame
baseline to week 523
Urgent care or unscheduled visits
Emergency department visits or other urgent care visits related to patient's dermatological condition
Time frame
baseline to week 524
Skin-specific Quality of Life Impairment
Changes in quality of life using the Dermatology Life Quality Index (DLQI). Minimum Score: 0 (no impact on quality of life). Maximum Score: 30 (extremely large impact on quality of life).
Time frame
baseline, 6 months, 12 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: